Skip to main content
Portrait of Kizzmekia Corbett

MDRPEDIA RECORDELITE · TIER IILIVING

Kizzmekia Corbett

Immunology (Viral Immunology) · Harvard T.H. Chan School of Public Health · Boston, United States

Suggest a correction
ELITE · TIER II · MDRPEDIA · LISTED ·MTIER II
h-index (OpenAlex)
50
Papers on record
10
Citations to these papers
21,890
Stature
Tier II
EVIDENCE RECORD

What this record is built on

Compared with the register: Internal Medicine · United States · How it works

I · SCHOLARSHIP

h-index
50 · 70th pct
OpenAlex✓ Verified
Papers on record
10
Crossref / DOI◐ Public record
Citations received
21,890
OpenAlex◐ Public record

II · PRACTICE

Licence
Not yet checked
Medical council○ Not reported
Board certification
—
Specialty boards○ Not reported
Registration ID
—
National registry○ Not reported
Institutions
2
Institution records◐ Public record

III · LEARNING & TEACHING

Trainees traced
Not yet traced
Lineage○ Not reported
Mentors traced
Not yet traced
Lineage○ Not reported
Invited talks
—
Congress programmes○ Not reported

IV · PEER STANDING

Honours
2
Awarding bodies◐ Public record
Techniques pioneered
1
Published literature◐ Public record
Ethics mark
Not yet audited
MDRPedia audit○ Not reported

Not on this record by design:Star ratingsAnonymous reviewsPaid placement

Record

Kizzmekia Corbett is an American immunologist and viral immunologist who was a key scientist behind the Moderna COVID-19 mRNA vaccine. She led the coronavirus team at the NIH Vaccine Research Center that designed the spike protein immunogen used in mRNA-1273, which has been administered to hundreds of millions worldwide.
IN PLAIN WORDS
  • Pioneered the Designed spike protein immunogen for mRNA-1273 (Moderna COVID vaccine), a technique still used by doctors worldwide
  • Research is cited 22K+ times by other doctors and scientists, indicating significant influence on medical research
  • Currently at Harvard T.H. Chan School of Public Health in Boston, United States

Institutions

  • Harvard T.H. Chan School of Public HealthAssistant Professor of Immunology and Infectious Diseases
  • NIH Vaccine Research CenterFormer Research Fellow
QUESTIONS YOU MIGHT ASK AT A FIRST VISIT
  • Is a procedure needed now, or can medicines and lifestyle changes help first?
  • What are the risks and benefits of each option for someone like me?
  • How many similar cases does your team see, and who will be involved in my care?
  • Who do I contact if symptoms come back after treatment?

Landmark papers

Papers on record
10
Citations received
21,890
Papers on record by year, 2016–2021

PUBLISHED IN Science · New England Journal of Medicine · Nature · Proceedings of the National Academy of Sciences · bioRxiv (Cold Spring Harbor Laboratory)

  1. 2020Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationSciencedoi 10.1126/science.abb25079,730 citations
  2. 2020An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportNew England Journal of Medicinedoi 10.1056/nejmoa20224833,464 citations
  3. 2020SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessNaturedoi 10.1038/s41586-020-2622-01,630 citations
  4. 2020Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsNew England Journal of Medicinedoi 10.1056/nejmoa20284361,603 citations
  5. 2017Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigenProceedings of the National Academy of Sciencesdoi 10.1073/pnas.17073041141,225 citations
Show all 10 papersShow fewer papers
  1. 2020Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman PrimatesNew England Journal of Medicinedoi 10.1056/nejmoa20246711,161 citations
  2. 2020Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion ConformationbioRxiv (Cold Spring Harbor Laboratory)doi 10.1101/2020.02.11.9444621,003 citations
  3. 2016Pre-fusion structure of a human coronavirus spike proteinNaturedoi 10.1038/nature17200825 citations
  4. 2020Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesCelldoi 10.1016/j.cell.2020.04.031653 citations
  5. 2021Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variantsSciencedoi 10.1126/science.abj4176596 citations

Honours

  • —TIME 100 Most Influential People (2021)
  • —Fortune 40 Under 40

Techniques pioneered

  • Designed spike protein immunogen for mRNA-1273 (Moderna COVID vaccine)

Career

  • 2014Joined NIH Vaccine Research CenterBegan research on coronavirus vaccines at the VRC
  • 2020Designed spike protein immunogen for Moderna vaccineLed design of the antigen used in the mRNA-1273 COVID-19 vaccine
  • 2021Moderna mRNA-1273 received full FDA approvalVaccine received full approval after demonstrating high efficacy
  • 2022Appointed to HarvardBecame assistant professor at Harvard T.H. Chan School of Public Health

Training and certification

  • University of Maryland, College Park
  • University of North Carolina at Chapel Hill

Lineage

We haven't traced this physician's mentors and trainees yet. If you trained with them, you can add to the record.Contribute lineage
FOR THE DOCTOR

Are you Kizzmekia Corbett?

Claim this record to correct details, add your lineage and teaching, and embed your seal. Claims are checked against your registration before anything changes.

Share this record

Share card for Kizzmekia Corbett